Clinical Trial Detail

NCT ID NCT03087071
Title Panitumumab in Combination With Trametinib in Cetuximab-Refractory Stage IV Colorectal Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements yes
Sponsors M.D. Anderson Cancer Center
Indications

colorectal adenocarcinoma

Therapies

Panitumumab

Trametinib

Age Groups: adult senior

Additional content available in CKB BOOST